X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BCLI

Closed

Brainstorm Cell Therapeutics Inc

1.11
-0.01 (-0.89%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.12
Day's Range: 1.0901 - 1.15
Send
When Written:
 
3.3
Brainstorm Cell Therapeutics Inc. is a biotechnology company that focuses on developing and commercializing innovative stem cell-based therapies for neurodegenerative diseases. The company's lead product candidate, NurOwn, is a personalized cell therapy that utilizes mesenchymal stem cells (MSCs) derived from a patient's own bone marrow to produce and secrete neurotrophic factors. These factors have the potential to promote the survival and growth of damaged neurons, which is believed to be a key mechanism for treating neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease.

Brainstorm Cell Therapeutics was founded in 2000 and is headquartered in New York, with research and development facilities in Israel. The company has partnerships with academic institutions and biopharmaceutical companies to advance its research and development efforts. Brainstorm Cell Therapeutics is publicly traded on the NASDAQ stock exchange under the ticker symbol BCLI.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X